These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 27884951)

  • 1. Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes.
    Emory H; Mizrahi N
    Diab Vasc Dis Res; 2017 Mar; 14(2):163-165. PubMed ID: 27884951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Subsequent Pregnancies in a Woman With Type 1 Diabetes: Artificial Pancreas Was a Gamechanger.
    Schütz-Fuhrmann I; Schütz AK; Eichner M; Mader JK
    J Diabetes Sci Technol; 2020 Sep; 14(5):972-973. PubMed ID: 32059616
    [No Abstract]   [Full Text] [Related]  

  • 3. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression.
    Emory H; Mizrahi N
    J Diabetes Sci Technol; 2016 Sep; 10(5):1203-4. PubMed ID: 26961977
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
    Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB
    Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
    Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
    Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating advances in insulin into clinical practice: Advances In insulin formulations.
    King A
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S9-17. PubMed ID: 24080573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic?
    Distiller LA; Joffe BI
    Diabetologia; 2006 Nov; 49(11):2793-4. PubMed ID: 17047914
    [No Abstract]   [Full Text] [Related]  

  • 10. Going low. This is your brain on hypoglycemia.
    Curry A
    Diabetes Forecast; 2015; 68(3):46-50. PubMed ID: 26668898
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.
    Dungan KM; Buse JB; Herman WH; Arakaki RF; Jiang HH; Jacobson JG; Fahrbach JL
    Diabetes Res Clin Pract; 2012 Jun; 96(3):e66-9. PubMed ID: 22421598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INITIATING AND INTENSIFYING INSULIN THERAPY IN GENERAL PRACTICE: INSUSTAR, AN OBSERVATIONAL BELGIAN PROSPECTIVE STUDY IN TYPE 2 DIABETES].
    Scheen AJ; Mathieu C; Nobels F
    Rev Med Liege; 2015 Sep; 70(9):423-31. PubMed ID: 26638442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes.
    Gordon J; McEwan P; Sabale U; Kartman B; Wolffenbuttel BH
    J Med Econ; 2016 Dec; 19(12):1167-1174. PubMed ID: 27356188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of care in people with type 1 diabetes after switching to insulin glargine-based regimens in a real-life setting: a long-term observational study.
    Dąbrowski M
    Int J Clin Pract; 2014 Aug; 68(8):1020-8. PubMed ID: 25040042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of insulin analogues as compared with human insulin in pregnancy.
    Toledano Y; Hadar E; Hod M
    Expert Opin Drug Saf; 2016 Jul; 15(7):963-73. PubMed ID: 27145344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical utility index for selecting an optimal insulin dosing algorithm for LY2605541 in patients with type 2 diabetes pretreated with basal insulin.
    Manner DH; Luo J; Qu Y; Berry S; Gaydos BL; Jacober SJ
    Diabetes Technol Ther; 2014 Aug; 16(8):499-505. PubMed ID: 24825416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
    Tan CY; Wilson DM; Buckingham B
    Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.